✦ LIBER ✦

A Phase II Study of KRN8602(MX2), a Novel Morpholino Anthracycline Derivative, in Patients with Recurrent Malignant Glioma

✍ Scribed by Jun-Ichi Kuratsu; Norio Arita; Kaoru Kurisu; Toru Uozumi; Toru Hayakawa; Yukitaka Ushio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of KRN8602, 3′-deamino-3′

✍ Noriyuki Katsumata; Toru Watanabe; Takeshi Tominaga; Makoto Ogawa; Isamu Adachi; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 72 KB

Second Line Chemotherapy with Docetaxel

✍ M. Sanson; M. Napolitano; R. Yaya; F. Keime-Guibert; Ph Broët; K. Hoang-Xuan; J. 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 34 KB

Phase II study of amonafide in patients

✍ Ralph Levitt; Jan C. Buckner; Terrence L. Cascino; Patrick A. Burch; Roscoe F. M 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 932 KB

A phase II study of carboplatin and chro

✍ P. Tang; G. Roldan; P.M.A Brasher; D. Fulton; W. Roa; A. Murtha; J.G. Cairncross 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 195 KB

A Randomized Phase II and Pharmacokineti

✍ S. Vincent Rajkumar; Joel M. Reid; Paul J. Novotny; Stephanie L. Safgren; Bernd 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 38 KB

Phase I study of sunitinib and irinoteca

✍ David A. Reardon; James J. Vredenburgh; April Coan; Annick Desjardins; Katherine 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 197 KB